Email Updates

You are here

AVAC in the News

  • Transgender and gender diverse activists and researchers, in partnership with the advocacy organisation AVAC, introduced a powerful manifesto to align HIV prevention research with their current realities and needs, entitled No Data No More at the 11th International AIDS Society Conference on HIV Science (IAS 2021) this week.

    July 22, 2021
    General
    aidsmap
  • Transgender women experience higher rates of HIV than most other populations. Globally, it’s estimated that 19 percent of trans women are living with HIV, 49 times the general population; conversely, not much is known about HIV among transgender men and nonbinary people. Given these facts, why aren’t more transgender and gender-diverse (TGD) people included in HIV-related research and prevention efforts?

    July 19, 2021
    General
    POZ
  • Almost one in five trans women globally are living with HIV – 49 times greater than the general population – while HIV in trans men is woefully understudied. Yet trans and gender-diverse (TGD) people are “frequently and often systematically left out of HIV prevention research and responses”, according to No Data No More, a global HIV prevention manifesto launched on Monday with the support of the non-profit HIV prevention organisation, AVAC.

    July 19, 2021
    General
    Health Policy Watch
  • The latest UN Declaration on AIDS does not speak more forcefully on the need to protect the human rights of key populations at risk for HIV, but there are significant shifts, including an unprecedented commitment to HIV combination prevention.

    July 16, 2021
    General
    Daily Maverick
  • US President Joe Biden has repeatedly praised the United States’ leadership in the global effort to end HIV/AIDS. Early this month, in marking the 40th anniversary of the start of the AIDS pandemic, the White House noted the “heartbreaking human toll” of nearly 35 million global AIDS deaths, the ongoing, high rate of new HIV infections worldwide, and the enormous progress being made against the epidemic by the US President’s Emergency Plan for AIDS Relief, or PEPFAR.

    June 28, 2021
    General
    Devex
  • Our framework offers policymakers, program implementers, and health care providers a road map for strategically assessing and monitoring progress toward PrEP-FP integration in their contexts.

    June 18, 2021
    Frontiers in Reproductive Health
  • On Tuesday (June 8), the UN General Assembly voted overwhelmingly to approve the 2021 Political Declaration on HIV and AIDS introduced as part of the now fifth High Level Meeting on HIV/AIDS. Previous Declarations were accepted by unanimous consent, following months of negotiations. This year’s Political Declaration includes much to applaud, including new ambitious targets for prevention, investment goals to ensure everyone who needs treatment has access to it, and a financial and moral commitment to end gender inequality, stigma and discrimination.

    June 14, 2021
    General
    Science Speaks
  • This week, the World Health Assembly (WHA), the governing body of the World Health Organization, is grappling with how best to prepare for and ideally prevent future pandemics. The WHA is taking as its starting point recommendations from the Independent Panel for Pandemic Preparedness and Response, which issued its findings earlier this month. The report is toothier and more specific than prior comparable commissions but has also generated debate over if and how to create a global governing body for pandemic action.

    May 30, 2021
    General
    Foreign Policy
  • Tuesday, May 18, marks HIV Vaccine Awareness Day (#HVAD) 2021. It’s designated as a time to thank the researchers, community leaders, health professionals and volunteers working to develop a vaccine to prevent HIV/AIDS. It’s also a day to educate the public about advancements in vaccine research and raise awareness about the need for an HIV vaccine.

    May 18, 2021
    POZ
  • The way in which the world has responded to COVID, has fundamentally changed ideas of what’s possible in vaccine development—but, regrettably, access to that scientific knowledge remains the property of a few drug companies and research institutions in wealthy countries.

    May 18, 2021
    Bhekisisa

Pages